￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of the half-life and dosage interval of Sunitinib (Sutent)

2026-02-01 22:25:32

Check Details
Analysis of the onset time and treatment course observation and suggestions of Tazetostat (Davico)

2026-02-01 22:25:32

Check Details
Life extension effect and patient reference after taking ceritinib/ceritinib (Zanda)

2026-02-01 22:25:32

Check Details
The best way to take Bestivan (Vileri) before or after meals and pay attention when taking it with food

2026-02-01 22:25:32

Check Details
Whether dabrafenib (Tefila) can treat melanoma and its efficacy evaluation

2026-02-01 22:25:32

Check Details
Study on whether withdrawal of axitinib (Inlida) will cause rapid tumor growth

2026-02-01 22:25:32

Check Details
Analysis of trametinib medical insurance reimbursement conditions and patients’ actual out-of-pocket expenses

2026-02-01 22:25:32

Check Details
How many days does it take for avatrombopag (Su Kexin) to achieve the desired effect?

2026-02-01 22:25:32

Check Details
Precautions and safe medication recommendations for taking Giritinib (Segatan)

2026-02-01 22:25:32

Check Details
Monthly cost and long-term medication economic analysis of canafenib/encofenib

2026-02-01 22:25:32

Check Details
Will the condition worsen after stopping imatinib (Gleevec) and risk analysis

2026-02-01 22:25:32

Check Details
Effects of ruxolitinib cream (Opzelura) in treating vitiligo and suggestions for treatment course observation

2026-02-01 22:25:32

Check Details
Category
相关知识